CHFR hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
about
CTNNA1 hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcomeRASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia.Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.Upregulation of the checkpoint protein CHFR is associated with tumor suppression in pancreatic cancers.Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.
P2860
CHFR hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
CHFR hypermethylation, a frequ ...... iated with an adverse outcome.
@en
CHFR hypermethylation, a frequ ...... iated with an adverse outcome.
@nl
type
label
CHFR hypermethylation, a frequ ...... iated with an adverse outcome.
@en
CHFR hypermethylation, a frequ ...... iated with an adverse outcome.
@nl
prefLabel
CHFR hypermethylation, a frequ ...... iated with an adverse outcome.
@en
CHFR hypermethylation, a frequ ...... iated with an adverse outcome.
@nl
P2093
P2860
P356
P1476
CHFR hypermethylation, a frequ ...... iated with an adverse outcome.
@en
P2093
P2860
P304
P356
10.1002/GCC.22322
P577
2015-11-06T00:00:00Z